← Back to patent-cliff list
CAS 163105-89-3
(6-methoxypyridin-3-yl)boronic acid
Codes: FIMEP-009
Application context (from source-drug indications)
Cushing's syndromeFimepinostatGliomaFimepinostatGlioblastomaFimepinostatDiffuse intrinsic pontine gliomaFimepinostat髓母细胞瘤Fimepinostat星形细胞瘤Fimepinostat
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Fimepinostat | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
methyl 3-aminothiophene-2-carboxylate→thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione→FIMEP-003→FIMEP-004→2-chloro-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde→1-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)-N-methylmethanamine→ethyl 2-chloropyrimidine-5-carboxylate→ethyl 2-(((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate→(6-methoxypyridin-3-yl)boronic acid→FIMEP-010→FIMEP-011→FIMEP-012→FIMEP-013→FIMEP-014→2-methoxypyridine→5-bromo-2-methoxypyridine→Fimepinostat
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.